On October 1, 2015, Allergan plc (NYSE: AGN), a leading global pharmaceutical company announced that it has successfully completed the acquisition of Kythera Biopharmaceuticals, Inc.
Allergan acquired Kythera in an all-cash transaction valued at approximately $2.1 billion.
Learn more about the combination at www.allergan.com
Who We Are: KYTHERA is a biopharmaceutical company focused on discovering, developing and commercializing innovative drugs and medical devices targeting large, global market opportunities.
What We Do: We translate our rigorous, yet elegant science into products that address much-cited, but under-treated aesthetic complaints.
Our Inspiration: Taking our name from the birthplace of Aphrodite on the Greek island of Kythera, we aspire to provide people with novel products that can lead to a healthy and positive self-image across all stages of life – a beautiful confidence.